9. Pharmacologic Approaches to Glycemic Treatment
Insulin Therapy Insulin treatment is essential for individuals with type 1 diabetes because the hallmark of type 1 diabetes is absent or near-absent β-cell function. In addition to hyperglycemia, insulinopenia can contribute to other metabolic disturbances like hypertriglyceridemia and ketoacidosis as well as tissue catabolism that can be life threatening. Severe metabolic decompensation can ...
There are presently nine classes of glucose-lowering agents used in the treatment of type 2 diabetes in Europe and several more are available in other regions (Table 1) [1, 2 ]. Lifestyle changes (principally diet, exercise and behavioural interventions) underpin all treatment algorithms. Non-insulin pharmacological agents use different glucose-lowering mechanisms and can be used as monotherapy ...
Section 9
Evaluate individuals with type 2 diabetes to determine whether they are candidates for GLP-1 or dual GIP/GLP-1 RA therapy . Evaluate all people on insulin therapy to determine whether they could benefit from continuous glucose monitoring.
Early initiation of pharmacologic therapy is associated with improved glycemic control and reduced long-term complications in type 2 diabetes . Drug classes used for the treatment of type 2 diabetes include the following:
Pharmacologic Therapies for Type 2 Diabetes
Type 2 diabetes (T2D) is a complex chronic disorder with an increasing prevalence. Treatment of T2D involves both lifestyle and pharmacologic interventions aimed at lowering blood glucose levels to help counteract the negative effects of long-term hyperglycemia. The range of pharmacologic treatments for T2D has grown substantially, with newer agents demonstrating not only glucose-lowering ...
AbstractType 2 diabetes (T2D) is a complex chronic disorder with an increasing prevalence. Treatment of T2D involves both lifestyle and pharmacologic interventions aimed at lowering blood glucose levels to help counteract the negative effects of long-term hyperglycemia. The range of pharmacologic tr …
Pharmacotherapy of Type 2 Diabetes
This review provides an in-depth analysis of pharmacotherapy in type II diabetes and expounds on main drug classes, pharmacodynamics, clinical effectiveness, adverse effects profile and combinations in treatment algorithms.
Choices for the treatment of type 2 diabetes mellitus (T2DM) have multiplied as our understanding of the underlying pathophysiologic defects has evolved. Treatment should target multiple defects in T2DM and follow a patient-centered approach that considers factors beyond glycemic control, including cardiovascular risk reduction. The American Association of Clinical Endocrinologists/American ...
Drug Therapies for Diabetes
The treatment of type 2 diabetes (T2D) necessitates a multifaceted approach that combines behavioral and pharmacological interventions to mitigate complications and sustain a high quality of life. Treatment encompasses the management of glucose levels, weight, cardiovascular risk factors, comorbidities, and associated complications through medication and lifestyle adjustments. Metformin, a ...
The list of medications for type 2 diabetes is long and can be confusing. Take time to learn about these medicines — how they're taken, what they do and what side effects they may cause. That can help you get ready to talk to your health care provider about diabetes treatment choices that are right for you.